Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Piotr S. Kowalski, Arnab Rudra, Lei Miao, et al.
Molecular Therapy (2019) Vol. 27, Iss. 4, pp. 710-728
Open Access | Times Cited: 898

Showing 1-25 of 898 citing articles:

Lipid nanoparticles for mRNA delivery
Xucheng Hou, Tal Zaks, Róbert Langer, et al.
Nature Reviews Materials (2021) Vol. 6, Iss. 12, pp. 1078-1094
Open Access | Times Cited: 2197
Nanoparticles in the clinic: An update
Aaron C. Anselmo, Samir Mitragotri
Bioengineering & Translational Medicine (2019) Vol. 4, Iss. 3
Open Access | Times Cited: 1397
Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Rumiana Tenchov, Robert E. Bird, Allison Curtze, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 16982-17015
Closed Access | Times Cited: 1349
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Namit Chaudhary, Drew Weissman, Kathryn A. Whitehead
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 11, pp. 817-838
Open Access | Times Cited: 984
Translational Applications of Hydrogels
Santiago Correa, Abigail K. Grosskopf, Hector Lopez Hernandez, et al.
Chemical Reviews (2021) Vol. 121, Iss. 18, pp. 11385-11457
Open Access | Times Cited: 719
mRNA vaccine for cancer immunotherapy
Lei Miao, Yu Zhang, Leaf Huang
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 694
On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
Sean A. Dilliard, Qiang Cheng, Daniel J. Siegwart
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 52
Open Access | Times Cited: 565
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Sebastián Scioli Montoto, Giuliana Muraca, María Esperanza Ruiz
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 488
The clinical progress of mRNA vaccines and immunotherapies
Ann Barbier, Allen Yujie Jiang, Peng Zhang, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 6, pp. 840-854
Open Access | Times Cited: 486
Nanomaterial Delivery Systems for mRNA Vaccines
Michael D. Buschmann, Manuel Carrasco, Suman Alishetty, et al.
Vaccines (2021) Vol. 9, Iss. 1, pp. 65-65
Open Access | Times Cited: 458
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Abishek Wadhwa, Anas Aljabbari, Abhijeet Lokras, et al.
Pharmaceutics (2020) Vol. 12, Iss. 2, pp. 102-102
Open Access | Times Cited: 454
Lipid nanoparticles for nucleic acid delivery: Current perspectives
Eleni Samaridou, James Heyes, Peter Lutwyche
Advanced Drug Delivery Reviews (2020) Vol. 154-155, pp. 37-63
Closed Access | Times Cited: 440
The Limitless Future of RNA Therapeutics
Tulsi Ram Damase, Roman Sukhovershin, Christian Boada, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 440
The promise of mRNA vaccines: a biotech and industrial perspective
Nicholas A. C. Jackson, Kent E. Kester, Danilo R. Casimiro, et al.
npj Vaccines (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 428
Recent advances in mRNA vaccine technology
Norbert Pardi, Michael J. Hogan, Drew Weissman
Current Opinion in Immunology (2020) Vol. 65, pp. 14-20
Closed Access | Times Cited: 424
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 415
Addressing the Cold Reality of mRNA Vaccine Stability
Daan J.A. Crommelin, Thomas J. Anchordoquy, David B. Volkin, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 3, pp. 997-1001
Open Access | Times Cited: 413
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 409
Nanotechnology approaches for global infectious diseases
Ameya R. Kirtane, Malvika Verma, Paramesh Karandikar, et al.
Nature Nanotechnology (2021) Vol. 16, Iss. 4, pp. 369-384
Closed Access | Times Cited: 391
Nanodelivery of nucleic acids
Bárbara B. Mendes, João Conniot, Aviram Avital, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 382
Self-assembled mRNA vaccines
Jeonghwan Kim, Yulia Eygeris, Mohit Gupta, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 83-112
Open Access | Times Cited: 379
mRNA vaccines manufacturing: Challenges and bottlenecks
Sara Sousa Rosa, D.M.F. Prazeres, Ana M. Azevedo, et al.
Vaccine (2021) Vol. 39, Iss. 16, pp. 2190-2200
Open Access | Times Cited: 364
Self-amplifying RNA vaccines for infectious diseases
Kristie Bloom, Fiona T. van den Berg, Patrick Arbuthnot
Gene Therapy (2020) Vol. 28, Iss. 3-4, pp. 117-129
Open Access | Times Cited: 341
Applications and Limitations of Dendrimers in Biomedicine
Adriana Aurelia Chiș, Carmen Maximiliana Dobrea, Claudiu Morgovan, et al.
Molecules (2020) Vol. 25, Iss. 17, pp. 3982-3982
Open Access | Times Cited: 331
Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery
Michael Segel, Blake Lash, Jingwei Song, et al.
Science (2021) Vol. 373, Iss. 6557, pp. 882-889
Open Access | Times Cited: 328
Page 1 - Next Page

Scroll to top